Judicial Watch, Inc. v. United States Food & Drug AdministrationJudicial Watch, Inc. v. United States Food & Drug Administration
MEMORANDUM OPINION
This matter comes before the Court on defendant’s motion to dismiss, or in the alternative, for summary judgment, plaintiffs opposition, and the reply thereto. Upon consideration of the filings, the entire record herein and the relevant law, the Court will deny defеndant’s motion to dismiss and grant defendant’s motion for summary judgment.
I. Procedural Posture
This case originated when plaintiff Judicial Watch, Inc. (“Judicial Watch”), filed a request with defendant, United States Food and Drug Administration (“FDA”) on August 22, 2006, under the Freedom of Information Act (“FOIA”) seeking “any or all communicаtions and/or correspondence between the FDA and Senator Hillary Rodham Clinton, ... [and/or] any agent and representative of Senator Hillary Rod-ham Clinton, and/or the Office of Senator Hillary Rodham Clinton regarding ‘.75 le-vonorgestrel,’ also sold undеr the trade name ‘Plan B.’ ” (“Clinton FOIA request”) (See Plaintiffs Amended Complaint (“Am. Compl.”)). Not having received any documents, plaintiff filed the instant suit on March 21, 2007. On April 18 and April 20, 2007, plaintiff filed two additional FOIA requests with defendant seeking records or documents pertaining to communicаtions between FDA and Senators Patty Murray and Michael Enzi, respectively, involving Plan B. (“Murray FOIA request” and “Enzi FOIA request”) (See Am. Compl.). The additional requests were virtually identical to the Clinton request.
Defendant subsequently filed a motion to dismiss on May 4, 2007, or in the alternative, for summary judgment. On July 6, 2007, this Court granted plaintiff leave to file an amended complaint to include
II. Background
Plaintiff Judicial Watch is a non-profit, educational organization incorporated under the laws of the District of Columbia. (Comply 3). Defendant FDA is an agency of the United States Government. (Id. ¶ 4). On August 22, 2006, plaintiff filed a request with defendant under the FOIA seeking records аnd documents pertaining to communications between FDA and Senator Clinton regarding Plan B. (See “Am. Compl.”). In a letter dated, August 24, 2006, defendant acknowledged receipt of plaintiffs FOIA request. (See id.).
Subsequent to the filing of this action, FDA sent plaintiff records responsive to thе Clinton FOIA request consisting of 28 pages of documents. (See Granger Decl. ¶ 5). On April 18 and April 20, 2007, plaintiff filed two additional requests under the FOIA seeking records and documents pertaining to communications between FDA and Senators Murray and Enzi. (See Am. Compl.). On April 20 and April 23, 2007, defendant sеnt plaintiff letters acknowledging receipt of plaintiffs FOIA requests. (See id.). FDA produced records responsive to plaintiffs Murray and Enzi requests on July 10, 2007. (See Def.’s Mem. from July 16, 2007).
Plaintiff challenges the reasonableness and adequacy of defendant’s search. (See Pl.’s Mem. from July 30, 2007). According to рlaintiff, certain records missing from defendant’s production demonstrate that defendant did not conduct a reasonable search. Plaintiff further contends that declarations submitted by defendant lack sufficient detail to demonstrate the reasonаbleness of defendant’s search.
III. Analysis
A. Defendant’s Motion to Dismiss, or in the Alternative, for Summary Judgment
1. Legal Standard
Pursuant to
On a motion to dismiss for failure to state a claim upon which relief can be granted pursuant to
Under
Fоr an agency to prevail on a motion for summary judgment in a FOIA action, it must prove that no genuine issue of material fact exists, viewing the facts in the light most favorable to the requester.
Weisberg v. U.S. Dep’t of Justice,
2. Mootness
Defendant FDA argues that plaintiffs claim is moot because FDA provided the requested records. Additionally, defendant argues that plaintiff does not state any claim for which relief may be granted. Fеderal courts may decide only “actual, ongoing controversies.”
Clarke v. United States,
In FOIA cases, a claim typically becomes moot once all documents are released tо the requester.
See Crooker v. U.S. State Dep’t,
3. Reasonableness and Adequacy of Defendant’s Search
To meet its summary judgment burden, “the agency must demonstrate that it has conducted a search reasonably calculated to uncover all relevant documents.”
Steinberg v. U.S. Dep’t of Justice,
Plaintiff argues that missing records demonstrate that FDA did not conduct a reasonable search for the requested documents. Specifically, plaintiff asserts that it is “unreasonable to think” that there were no notes or written information from FDA’s briefing of three senators.
(See
Pl.’s Mem. from July 30, 2007). Plaintiff also relies on public statements made by Senators Clinton and Murray that suggest, according to plaintiff, that it is “highly unlikely” that FDA does not have аdditional records responsive to plaintiffs request.
(See id.).
The D.C. Circuit has made clear that a FOIA requestor who challenges the reasonableness of a search “because the agency did not find responsive documents that [the requester] clаims must exist” cannot sustain that challenge when he “provides no proof that these documents exist and [offers only] his own conviction that [an event] was of such importance that records must have been created.”
Oglesby,
An agency may use reasonably detailed, non-conclusory affidavits to demonstrate thаt it conducted a reasonable search in accordance with the FOIA.
See Ground Saucer Watch, Inc. v. CIA,
In the instant matter, FDA searched each officе identified as likely to have responsive documents and provided detailed information about the types of searches conducted in those offices. (See July Granger Decl. ¶ 12). In response to plaintiffs assertions, FDA provided plaintiff and this Court with supplemental declarations detailing its general search methodology and the search for records conducted in this case. 1 Each of the supplemental declarations further contain detailed descriptions of the files that were sеarched and the search terms that were used for the searches. (See Supp. Gran-ger Decl. ¶¶ 4-6; Supp. Mungo Decl. ¶¶ 4-5; Supp. Palmer Decl. ¶¶ 6-8; Supp. Schifter Decl. ¶ 6-8.)
This Court is satisfied that FDA has acted in good faith toward the plaintiff and this Court. In light of the original and supрlemental declarations submitted by the defendant, it is clear to this Court that FDA satisfied its obligation under the FOIA to provide an adequate and reasonable search.
III. CONCLUSION
For the foregoing reasons, this Court concludes that FDA has met its summary judgment burden of demonstrаting its search conducted in response to plaintiffs FOIA requests was reasonably conducted and thus adequate. Accordingly, this Court will deny defendant’s motion to dismiss and grant defendant’s motion [25] for summary judgment.
A separate Order accompanies this Memorandum Opinion.
Notes
. Plaintiff filed no motion for leave to file a surreply challenging defendant's supplemental declarations.